Proto-oncogene tyrosine-protein kinase
From Proteopedia
| Line 1: | Line 1: | ||
| - | {{STRUCTURE_1fmk| PDB=1fmk | SIZE= | + | {{STRUCTURE_1fmk| PDB=1fmk | SIZE=400| SCENE= |right| CAPTION=Human proto-oncogene tyrosine-protein kinase Src kinase, SH2, SH3, C terminal domains with phosphotyrosine, [[1fmk]] }} |
Non-receptor '''proto-oncogene tyrosine-protein kinase''' (NTPK) are enzymes which transfer a phosphate group from ATP to proteins. For details of Proto-oncogene tyrosine-protein kinase SRC see [[SRC]]. | Non-receptor '''proto-oncogene tyrosine-protein kinase''' (NTPK) are enzymes which transfer a phosphate group from ATP to proteins. For details of Proto-oncogene tyrosine-protein kinase SRC see [[SRC]]. | ||
| Line 8: | Line 8: | ||
==3D structures of proto-oncogene tyrosine-protein kinase== | ==3D structures of proto-oncogene tyrosine-protein kinase== | ||
| + | |||
| + | ''Updated December 2011'' | ||
'''Proto-oncogene tyrosine-protein kinase SRC''' | '''Proto-oncogene tyrosine-protein kinase SRC''' | ||
| - | [[3lok]], [[3geq]], [[2qi8]] – cNTPK SRC kinase domain (mutant) – chicken<br /> | + | [[3lok]], [[3geq]], [[2qi8]], [[3of0]] – cNTPK SRC kinase domain (mutant) – chicken<br /> |
[[3fj5]] - cNTPK SRC SH3 domain<br /> | [[3fj5]] - cNTPK SRC SH3 domain<br /> | ||
[[1f2f]] - cNTPK SRC SH2 domain (mutant) <br /> | [[1f2f]] - cNTPK SRC SH2 domain (mutant) <br /> | ||
| Line 23: | Line 25: | ||
[[1f1w]] - cNTPK SRC SH2 domain (mutant) + phosphopeptide<br /> | [[1f1w]] - cNTPK SRC SH2 domain (mutant) + phosphopeptide<br /> | ||
[[3g6g]], [[3f6x]], [[3el7]], [[3el8]], [[3en4]], [[3en5]], [[3en6]], [[3en7]], [[2hwo]], [[2hwp]] - cNTPK SRC kinase domain + inhibitor<br /> | [[3g6g]], [[3f6x]], [[3el7]], [[3el8]], [[3en4]], [[3en5]], [[3en6]], [[3en7]], [[2hwo]], [[2hwp]] - cNTPK SRC kinase domain + inhibitor<br /> | ||
| - | [[3f3v]], [[3f3w]], [[3g6h]], [[3f3t]], [[3f3u]], [[2qlq]], [[2qq7]] - cNTPK SRC kinase domain (mutant) + inhibitor<br /> | + | [[3f3v]], [[3f3w]], [[3g6h]], [[3f3t]], [[3f3u]], [[2qlq]], [[2qq7]], [[3oez]], [[3svv]] - cNTPK SRC kinase domain (mutant) + inhibitor<br /> |
[[3g5d]] - cNTPK SRC kinase domain (mutant) + cancer drug<br /> | [[3g5d]] - cNTPK SRC kinase domain (mutant) + cancer drug<br /> | ||
[[2oiq]] - cNTPK SRC kinase domain + cancer drug<br /> | [[2oiq]] - cNTPK SRC kinase domain + cancer drug<br /> | ||
| Line 47: | Line 49: | ||
[[1ijr]] - hNTPK LCK SH2 domain + phosphotyrosine analog<br /> | [[1ijr]] - hNTPK LCK SH2 domain + phosphotyrosine analog<br /> | ||
| - | [[3ad4]], [[3ad5]], [[3ad6]], [[3kmm]], [[3ac1]], [[3ac2]], [[3ac3]], [[3ac4]], [[3ac5]], [[3ac8]], [[3acj]], [[3ack]], [[3kxz]], [[2zyb]], [[3byo]], [[ | + | [[1fbz]] - hNTPK LCK SH2 domain + inhibitor<br /> |
| + | [[3ad4]], [[3ad5]], [[3ad6]], [[3kmm]], [[3ac1]], [[3ac2]], [[3ac3]], [[3ac4]], [[3ac5]], [[3ac8]], [[3acj]], [[3ack]], [[3kxz]], [[2zyb]], [[3byo]], [[2zm1]], [[2zm4]], [[3bym]], [[3bys]], [[3byu]], [[3b2w]], [[2of2]], [[2of4]], [[2ofu]], [[2ofv]], [[2og8]] – hNTPK LCK kinase domain+ inhibitor<br /> | ||
[[2pl0]] - hNTPK LCK kinase domain + cancer drug<br /> | [[2pl0]] - hNTPK LCK kinase domain + cancer drug<br /> | ||
'''Proto-oncogene tyrosine-protein kinase FYN''' | '''Proto-oncogene tyrosine-protein kinase FYN''' | ||
| - | [[3h0f]], [[3h0h]], [[ | + | [[3h0f]], [[3h0h]], [[3h0i]], [[3cqt]] - hNTPK FYN SH3 domain (mutant) <br /> |
[[1zbj]] - hNTPK FYN SH3 domain – NMR<BR /> | [[1zbj]] - hNTPK FYN SH3 domain – NMR<BR /> | ||
[[1g83]] - hNTPK FYN SH2, SH3 domains (mutant) | [[1g83]] - hNTPK FYN SH2, SH3 domains (mutant) | ||
Revision as of 11:34, 14 December 2011
Template:STRUCTURE 1fmk
Non-receptor proto-oncogene tyrosine-protein kinase (NTPK) are enzymes which transfer a phosphate group from ATP to proteins. For details of Proto-oncogene tyrosine-protein kinase SRC see SRC.
3D structures of proto-oncogene tyrosine-protein kinase
Updated December 2011
Proto-oncogene tyrosine-protein kinase SRC
3lok, 3geq, 2qi8, 3of0 – cNTPK SRC kinase domain (mutant) – chicken
3fj5 - cNTPK SRC SH3 domain
1f2f - cNTPK SRC SH2 domain (mutant)
1yi6 – hNTPK SRC C terminal - human
1yoj - hNTPK SRC kinase domain (mutant)
1fmk - hNTPK SRC kinase, SH2, SH3, C terminal domains
Binary complex
1p13 - cNTPK SRC SH2 domain + peptide
1f1w - cNTPK SRC SH2 domain (mutant) + phosphopeptide
3g6g, 3f6x, 3el7, 3el8, 3en4, 3en5, 3en6, 3en7, 2hwo, 2hwp - cNTPK SRC kinase domain + inhibitor
3f3v, 3f3w, 3g6h, 3f3t, 3f3u, 2qlq, 2qq7, 3oez, 3svv - cNTPK SRC kinase domain (mutant) + inhibitor
3g5d - cNTPK SRC kinase domain (mutant) + cancer drug
2oiq - cNTPK SRC kinase domain + cancer drug
3dqw - cNTPK SRC kinase domain (mutant) + ATPγS
3dqx - cNTPK SRC kinase domain + ATPγS
3d7t - cNTPK SRC kinase domain + inactivator CSK (mutant)
3d7u - cNTPK SRC kinase domain + inactivator CSK
2h8h, 2bdf, 2bdj – hNTPK SRC + inhibitor – human
1yol, 1yom - hNTPK SRC kinase domain (mutant) + inhibitor
1y57 - hNTPK SRC kinase, SH2, SH3 domains + inhibitor
1ksw - hNTPK SRC kinase, SH2, SH3 domains (mutant) + benzyl ADP
1o41, 1o42, 1o43, 1o44, 1o45, 1o46, 1o47, 1o48, 1o49, 1o4a, 1o4b, 1o4c, 1o4d, 1o4e, 1o4f, 1o4g, 1o4h, 1o4j, 1o4i, 1o4k, 1o4l, 1o4m, 1o4n, 1o4o, 1o4p, 1o4q, 1o4r - hNTPK SRC SH2 domain + inhibitor
2src - hNTPK SRC kinase, SH2, SH3, C terminal domains + AMP-PNP
Proto-oncogene tyrosine-protein kinase LCK
2iim - hNTPK LCK SH3 domain
1kik, 1h92 - hNTPK LCK SH3 domain - NMR
1x27 - hNTPK LCK SH2, SH3 domains
3lck - hNTPK LCK kinase domain
Binary complex
1ijr - hNTPK LCK SH2 domain + phosphotyrosine analog
1fbz - hNTPK LCK SH2 domain + inhibitor
3ad4, 3ad5, 3ad6, 3kmm, 3ac1, 3ac2, 3ac3, 3ac4, 3ac5, 3ac8, 3acj, 3ack, 3kxz, 2zyb, 3byo, 2zm1, 2zm4, 3bym, 3bys, 3byu, 3b2w, 2of2, 2of4, 2ofu, 2ofv, 2og8 – hNTPK LCK kinase domain+ inhibitor
2pl0 - hNTPK LCK kinase domain + cancer drug
Proto-oncogene tyrosine-protein kinase FYN
3h0f, 3h0h, 3h0i, 3cqt - hNTPK FYN SH3 domain (mutant)
1zbj - hNTPK FYN SH3 domain – NMR
1g83 - hNTPK FYN SH2, SH3 domains (mutant)
Binary complex
2dq7 - hNTPK FYN kinase domain + antibiotic
1m27 - hNTPK FYN SH3 domain + SH2 domain protein 1A + SLAM
Proto-oncogene tyrosine-protein kinase ABL1
3eg0, 3eg2, 3eg3, 3egu - hNTPK ABL1 SH3 domain (mutant)
2fo0 - hNTPK ABL1 SH2]], SH3 domains (mutant)
1zzp - hNTPK ABL1 F-actin binding domain – NMR
1opj, 1opk, 1opl - mNTPK ABL1 kinase domain – mouse
Binary complex
3eg1, 2o88 - hNTPK ABL1 SH3 domain (mutant) + peptide
1ju5 - hNTPK ABL1 SH3 domain + CRK SH2 domain + CRK phosphopeptide - NMR
3k2m - hNTPK ABL1 SH2 domain + monobody A4
2e2b, 2hiw - hNTPK ABL1 kinase domain + inhibitor
2f4j - hNTPK ABL1 kinase domain (mutant) + inhibitor
3cs9, 2hyy, 2hz0, 2hz4, 2hzi, 2hzn, 2gqg - hNTPK ABL1 kinase domain + cancer drug
2g1t - hNTPK ABL1 kinase domain + peptide
3ik3, 1m52, 1fpu - mNTPK ABL1 kinase domain + inhibitor
1iep - mNTPK ABL1 kinase domain + cancer drug
3dk3, 3dk6, 3dk7, 2qoh, 2v7a, 2z60 - mNTPK ABL1 kinase domain (mutant) + inhibitor
Proto-oncogene tyrosine-protein kinase FER
2kk6 - hNTPK FER SH2 domain
Proto-oncogene tyrosine-protein kinase KIT
2ec8 - hNTPK KIT extracellular domain
Binary complex
3g0e, 3g0f - hNTPK KIT kinase domain (mutant) + cancer drug
2e9w, 2o26 - hNTPK KIT extracellular domain + stem cell factor
Proto-oncogene tyrosine-protein kinase FES
3bkb - hNTPK FES kinase, SH2 domains
2dcr, 1wqu - hNTPK FES SH2 domain – NMR
Binary complex
3cd3, 3cbl - hNTPK FES kinase, SH2 domains + peptide
Proto-oncogene tyrosine-protein kinase MER
2p0c - hNTPK MER kinase domain
2dbj - hNTPK MER precursor fibronectin domain – NMR
Binary complex
3bpr - hNTPK MER kinase domain + inhibitor
3brb - hNTPK MER kinase domain + ADP
Proto-oncogene tyrosine-protein kinase YES
2hda - hNTPK YES SH3 domain
Proteopedia Page Contributors and Editors (what is this?)
Michal Harel, Alexander Berchansky, Joel L. Sussman, Jaime Prilusky
